Company Profiles

driven by the PitchBook Platform

Chase Pharmaceuticals

Description

Provider of medications for the treatment of neurological and psychiatric diseases. The company focuses on the development of medications for the treatment of Alzheimer's disease.

2007

Founded

M&A

Status

11-50

Employees

M&A

Latest Deal Type

$1B

Latest Deal Amount

$38.2M

Total Amount Raised

Description

Provider of medications for the treatment of neurological and psychiatric diseases. The company focuses on the development of medications for the treatment of Alzheimer's disease.

Website:

www.chasepharmaceuticals.com

Ownership Status

Acquired/Merged (Operating Subsidiary)

Financing Status

Formerly VC-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

1825 K Street Northwest Suite 510 Washington, DC 20006United States +1 (202) 792-4621
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Chase Pharmaceuticals's full profile, request a free trial.

Chase Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Chase Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Chase Pharmaceuticals Executive Team (5)

NameTitleBoard
Seat
Contact
Info
John Siebert Ph.DSenior Advisor
Douglas Ingram JDChief Executive Officer & Board Member
Scott GiacobelloChief Financial Officer & Secretary
Thomas Chase MDChief Scientific Officer, Board Member & Co-Founder
Kathleen Clarence-Smith Ph.DChief Medical Officer & Co-Founder
John Siebert Ph.D Senior Advisor
Douglas Ingram JD Chief Executive Officer & Board Member
Scott Giacobello Chief Financial Officer & Secretary
Thomas Chase MD Chief Scientific Officer, Board Member & Co-Founder
Kathleen Clarence-Smith Ph.D Chief Medical Officer & Co-Founder

Chase Pharmaceuticals Board Members (4)

NameRepresentingRoleSinceContact
Info
Douglas Ingram JDChase PharmaceuticalsChief Executive Officer & Board Member000 0000
Karoly Nikolich Ph.DSelfBoard Member000 0000
Stephen Cunningham MDChase PharmaceuticalsBoard Member000 0000
Thomas Chase MDChase PharmaceuticalsChief Scientific Officer, Board Member & Co-Founder000 0000
Douglas Ingram JD Chief Executive Officer & Board Member Chase Pharmaceuticals
Karoly Nikolich Ph.D Board Member Self
Stephen Cunningham MD Board Member Chase Pharmaceuticals
Thomas Chase MD Chief Scientific Officer, Board Member & Co-Founder Chase Pharmaceuticals
Request full access to PitchBook